Enrico Cipro Vanni Buys 40,000 Shares of Advanced Oncotherapy PLC (AVO) Stock

Advanced Oncotherapy PLC (LON:AVO) insider Enrico Cipro Vanni bought 40,000 shares of the company’s stock in a transaction on Thursday, January 11th. The shares were acquired at an average price of GBX 55 ($0.75) per share, with a total value of £22,000 ($29,834.55).

Shares of Advanced Oncotherapy PLC (LON:AVO) traded up GBX 1 ($0.01) during trading on Friday, hitting GBX 54.50 ($0.74). 78,169 shares of the company’s stock traded hands, compared to its average volume of 321,124. The company has a market cap of $127.30 and a PE ratio of -340.63. Advanced Oncotherapy PLC has a 52 week low of GBX 9.75 ($0.13) and a 52 week high of GBX 87 ($1.18).

COPYRIGHT VIOLATION NOTICE: “Enrico Cipro Vanni Buys 40,000 Shares of Advanced Oncotherapy PLC (AVO) Stock” was reported by American Banking News and is the sole property of of American Banking News. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at https://www.americanbankingnews.com/2018/01/12/enrico-cipro-vanni-buys-40000-shares-of-advanced-oncotherapy-plc-avo-stock.html.

About Advanced Oncotherapy

Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device and management of healthcare related property.

Insider Buying and Selling by Quarter for Advanced Oncotherapy (LON:AVO)

Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply